Cubist Systematic Strategies’s IGM Biosciences IGMS Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $13.8K | Buy |
12,316
+2,408
| +24% | +$2.7K | ﹤0.01% | 1403 |
|
|
2025
Q1 | $11.4K | Sell |
9,908
-20,240
| -67% | -$23.3K | ﹤0.01% | 1362 |
|
|
2024
Q4 | $184K | Buy |
+30,148
| New | +$184K | ﹤0.01% | 1194 |
|
|
2024
Q3 | – | Sell |
-3,300
| Closed | -$22.7K | – | 1836 |
|
|
2024
Q2 | $22.7K | Buy |
+3,300
| New | +$22.7K | ﹤0.01% | 1280 |
|
|
2023
Q3 | – | Sell |
-10,500
| Closed | -$96.9K | – | 2266 |
|
|
2023
Q2 | $96.9K | Buy |
10,500
+8,311
| +380% | +$76.7K | ﹤0.01% | 1819 |
|
|
2023
Q1 | $30.1K | Buy |
+2,189
| New | +$30.1K | ﹤0.01% | 2589 |
|
|
2022
Q4 | – | Sell |
-19,801
| Closed | -$450K | – | 3413 |
|
|
2022
Q3 | $450K | Sell |
19,801
-2,599
| -12% | -$59.1K | ﹤0.01% | 2557 |
|
|
2022
Q2 | $404K | Buy |
22,400
+14,093
| +170% | +$254K | ﹤0.01% | 2755 |
|
|
2022
Q1 | $222K | Sell |
8,307
-25,140
| -75% | -$672K | ﹤0.01% | 2976 |
|
|
2021
Q4 | $981K | Buy |
33,447
+27,859
| +499% | +$817K | 0.01% | 1933 |
|
|
2021
Q3 | $367K | Buy |
+5,588
| New | +$367K | ﹤0.01% | 2229 |
|
|
2021
Q2 | – | Sell |
-5,284
| Closed | -$405K | – | 2986 |
|
|
2021
Q1 | $405K | Sell |
5,284
-2,322
| -31% | -$178K | 0.01% | 2078 |
|
|
2020
Q4 | $672K | Buy |
7,606
+3,425
| +82% | +$303K | 0.01% | 1616 |
|
|
2020
Q3 | $309K | Buy |
+4,181
| New | +$309K | ﹤0.01% | 1976 |
|
|
2019
Q4 | – | Sell |
-5,306
| Closed | -$94K | – | 2471 |
|
|
2019
Q3 | $94K | Buy |
+5,306
| New | +$94K | ﹤0.01% | 1949 |
|